Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN Synergy Pharmaceuticals Inc.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Doctoral candidate Becky Hansis-O’Neill’s research helps build understanding of tarantulas
The Saint Louis Zoo and Missouri Department of Conservation have taken an interest in her work.
MORE IN Synergy Pharmaceuticals Inc.
LATEST NEWS
- Doctoral candidate Becky Hansis-O’Neill’s research helps build understanding of tarantulas
- Supply chain department research helps Beauty Supply Refresh adjust to market fluctuations
- Alumni, current and maybe someday future students turn out for fifth annual UMSL 5K
- Eye on UMSL: Record party
- Optometry student Quynh Nguyen named to 2025-26 CooperVision Student Myopia Leadership Society
- Entrepreneurship and Innovation Center announces first-ever All-Campus Pitch Competition
- UMSL Tritons weekly rewind
- Assistant Professor Dan Grossman explores the ‘maybe’ problem
- UMSL awarded $2.4 million grant to continue expanding Succeed Program
- Finance Career Conference offers students opportunity to lead panel, fireside chat sessions
